Delivery Order SPE2DB22D1106-SPE2DB25FDYG5

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TUBERSOL 5T UNIT/0.1 ML VIALML. The contract has a ceiling value of $1,709.38 and an ultimate completion date of April 27, 2023. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,200.00, is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIALML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 14, 2025. This award is not associated with a set-aside designation. AmerisourceBergen holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,442.74 firm fixed-price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999 through December 2025, for the delivery of a wide range...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation, to provide TUBERSOL 5T UNIT/0.1 ML VIAL 5ML pharmaceutical products. The contract has a potential value of $1,262.58 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA through December 2025, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,710.88, is for the supply of Tubersol 5T Unit/0.1 ML Vial ML, a tuberculosis test product. The contract is a firm fixed-price delivery order, with an ultimate completion date of July 18, 2024. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp, through its Corporate Office Division, has been...
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product. The firm-fixed-price delivery order, valued at $4,208.60, has a period of performance through November 19, 2024. Amerisourcebergen is the prime contractor, and this award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which the company holds with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.00 firm fixed-price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIALML, a medical product. The award has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,617.33 firm fixed-price delivery order (Contract ID: SPE2DB20D1004|SPE2DB24FF7F0) is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, with an ultimate completion date of April 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order (SPE2DB24FWT45) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TUBERSOL 5T UNIT/0.1 ML VIALML. The contract has a ceiling value of $4,572.56 and is a firm fixed price type. It is not designated as a set-aside contract. The award date is August 23, 2024, and the ultimate completion date is August 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,306.20 firm fixed-price delivery order covers the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDYG5
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, valued at $1,070.95, with a completion date of February 11, 2025. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 9:49 AM